Abatacept versus other biologics in methotrexate inadequate responders with rheumatoid arthritis: you like tomato and I like tomahto... let's call the whole thing off

In the absence of head-to-head trials, analysis of available data from randomized clinical trials allows for comparison of the efficacy of biologic agents for the treatment of rheumatoid arthritis. Methotrexate (MTX) inadequate responder trials provide data suggesting no major differences among any...

Descripción completa

Detalles Bibliográficos
Autor principal: Yazici, Yusuf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392802/
https://www.ncbi.nlm.nih.gov/pubmed/22353683
http://dx.doi.org/10.1186/ar3688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392802/
https://www.ncbi.nlm.nih.gov/pubmed/22353683
http://dx.doi.org/10.1186/ar3688

Ejemplares similares